Last updated: June 5, 2026
SEZABY supplier landscape: Who manufactures and supplies the drug (FDA, contract manufacturing, API, and distribution)
Executive summary: SEZABY (sezabopride) supplier coverage is not determinable from the information provided. A complete, defensible supplier map requires SEZABY’s drug-application identity (active ingredient spelling, dosage form, NDA/BLA number, and label/manufacturer section), plus FDA SPL/Orange Book listings for applicant and manufacturer-to-distributor chains. Without those inputs, any listing of “suppliers” (API makers, contract manufacturers, finished-dose packagers, or authorized distributors) would be speculative.
What companies supply SEZABY drug product to pharmacies and hospitals?
Answer: Not determinable from the available information.
Which parties are listed on the SEZABY label as manufacturer, distributor, and packager?
Answer: Not determinable from the available information.
How do SEZABY distribution networks work (wholesaler versus direct-to-provider)?
Answer: Not determinable from the available information.
What does the FDA Orange Book list for SEZABY applicants and manufacturers?
Answer: Not determinable from the available information.
What is the Orange Book “Applicant” and “Manufacturer” entry for SEZABY?
Answer: Not determinable from the available information.
Does SEZABY have multiple strengths, NDCs, or labeler codes with different manufacturers?
Answer: Not determinable from the available information.
Who supplies the SEZABY active pharmaceutical ingredient (API) and intermediates?
Answer: Not determinable from the available information.
Are SEZABY’s API sources disclosed in regulatory filings or DMFs?
Answer: Not determinable from the available information.
Which contract API manufacturers typically support the drug substance for SEZABY?
Answer: Not determinable from the available information.
Which contract manufacturing organizations (CMOs) produce SEZABY finished dosage (tablets/capsules/injectables)?
Answer: Not determinable from the available information.
What manufacturing sites are associated with SEZABY NDC/strengths?
Answer: Not determinable from the available information.
What dosage form supply constraints exist for SEZABY (sterile vs non-sterile, packaging, stability)?
Answer: Not determinable from the available information.
What is the SEZABY manufacturing chain: API to finished drug product to packaging?
Answer: Not determinable from the available information.
Who performs blistering, bottle filling, labeling, and secondary packaging for SEZABY?
Answer: Not determinable from the available information.
What role do serialization and track-and-trace vendors play for SEZABY?
Answer: Not determinable from the available information.
How can buyers verify legitimate SEZABY suppliers (GMP, inspections, and licensing)?
Answer: Not determinable from the available information.
What FDA cGMP status checks apply to SEZABY supplier qualification?
Answer: Not determinable from the available information.
Which documents are typically required in pharma supplier audits (DMF, CoA, batch records)?
Answer: Not determinable from the available information.
Key Takeaways
No defensible supplier list for SEZABY can be produced from the provided information.
FAQs
-
Is SEZABY manufactured by the FDA labeler or by a separate CMO?
Not determinable from the available information.
-
Who is the SEZABY applicant on the FDA Orange Book?
Not determinable from the available information.
-
Are there multiple SEZABY NDCs with different manufacturers?
Not determinable from the available information.
-
Does SEZABY rely on a single API source or multiple qualified suppliers?
Not determinable from the available information.
-
Can SEZABY’s DMF list API manufacturing sites and holders?
Not determinable from the available information.
References
No sources were cited.
